Mirati Therapeutics shares owned by Smith Asset Management Group
Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Smith Asset Management Group
from 13F filings
Historical chart of Smith Asset Management Group investment in Mirati Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mirati Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Mirati Therapeutics by Smith Asset Management Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2021-06-30 | $8.0k | 50 | 160.00 |
2021-03-31 | $9.0k | 50 | 180.00 |
2020-12-31 | $294k | 1.3k | 219.40 |
2020-09-30 | $223k | 1.3k | 166.42 |
2020-06-30 | $106k | 930 | 113.98 |
2020-03-31 | $73k | 950 | 76.84 |
2019-12-31 | $122k | 950 | 128.42 |
2019-09-30 | $74k | 950 | 77.89 |
More positions owned by Smith Asset Management Group
View all positions for Smith Asset Management Group